The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-2-yl)thieno[2,3-b]pyridin-4-yloxy)phenylcarbamothioyl)-2-phenylacetamide ID: ALA3764474
Chembl Id: CHEMBL3764474
PubChem CID: 127041351
Max Phase: Preclinical
Molecular Formula: C26H20FN5O2S2
Molecular Weight: 517.61
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1ccnc1-c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2s1
Standard InChI: InChI=1S/C26H20FN5O2S2/c1-32-12-11-28-24(32)22-15-18-20(9-10-29-25(18)36-22)34-21-8-7-17(14-19(21)27)30-26(35)31-23(33)13-16-5-3-2-4-6-16/h2-12,14-15H,13H2,1H3,(H2,30,31,33,35)
Standard InChI Key: ZMZOKLZTXMCMNW-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 517.61Molecular Weight (Monoisotopic): 517.1042AlogP: 5.68#Rotatable Bonds: 6Polar Surface Area: 81.07Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.22CX Basic pKa: 5.26CX LogP: 5.39CX LogD: 5.38Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -1.99
References 1. Zhang J, Jiang X, Jiang Y, Guo M, Zhang S, Li J, He J, Liu J, Wang J, Ouyang L.. (2016) Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs., 108 [PMID:26717201 ] [10.1016/j.ejmech.2015.12.016 ]